D-Serine


Endogenous NMDA receptor co-agonist

D-stereoisomer of serine; an endogenous obligatory co-agonist at the NMDA receptor glycine site.

Abstract

D-serine ((R)-2-amino-3-hydroxypropanoic acid; CAS 312-84-5; molecular formula C3H7NO3; molecular weight 105.09) is the D-stereoisomer of serine, an endogenous obligatory co-agonist at the glycine site of NMDA receptors. The compound is biosynthesized in the brain by serine racemase (the enzyme that converts L-serine to D-serine) and is metabolized by D-amino acid oxidase (DAAO). D-serine is the principal endogenous co-agonist for synaptic NMDA receptors in the cortex and hippocampus, while glycine itself co-agonizes extrasynaptic NMDA receptors. Pharmacologically, exogenous D-serine elevates NMDA receptor function, with research interest in schizophrenia (where reduced NMDA function is hypothesized as a contributor to negative symptoms and cognitive deficits) and depression (NMDA modulation as antidepressant target). Phase 2 trials in schizophrenia have shown small effects. Plasma half-life is approximately 4 hours; oral bioavailability is moderate. The DAAO inhibitor approach is an alternative to direct D-serine administration. Used as the canonical NMDA glycine-site co-agonist in research.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs

Previous monograph
Next monograph